SFL’s CEO, Shayesteh Fürst-Ladani, and SFL Pharma’s General Manager, François Bersier, will represent the SFL Group at BIOtech Japan 2018, taking place in Tokyo on 27-29 June 2018. The event is Asia’s leading conference for the biotechnology and pharmaceutical industries and features an exhibition, a conference, a partnering system and an academic forum. This year, over 1,500 exhibitors from all over the world will attend, and 350 presentations will give an overview of the industry trends in Japan and Asia.

SFL supports clients globally through its multi-disciplinary team, and SFL Pharma acts as Marketing Authorization Holder (MAH), providing full support to pharma companies who do not have a registered subsidiary in Switzerland. Shayesteh and François are looking forward to welcoming you at booth B35.